abiraterone
Showing 26 - 50 of 55
Newly Diagnosed Oligometastatic Prostate Cancer Trial in Long Beach, West Los Angeles, Richmond (procedure, radiation, drug)
Active, not recruiting
- Newly Diagnosed Oligometastatic Prostate Cancer
- radical prostatectomy
- +4 more
-
Long Beach, California
- +2 more
Mar 16, 2022
Metastatic Castration Resistant Prostate Cancer Trial in Atlanta, Minneapolis, Nashville (Rucaparib, Enzalutamide, Abiraterone)
Active, not recruiting
- Metastatic Castration Resistant Prostate Cancer
- Rucaparib
- +2 more
-
Atlanta, Georgia
- +2 more
Jan 24, 2022
Castration-Sensitive Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8 Trial in Atlanta
Not yet recruiting
- Castration-Sensitive Prostate Carcinoma
- +2 more
- Abiraterone
- +9 more
-
Atlanta, Georgia
- +1 more
Feb 8, 2023
Prostate Cancer Metastatic, Metastasis Trial in Netherlands (Cabazitaxel, Abiraterone, Enzalutamide)
Completed
- Prostate Cancer Metastatic
- Metastasis
- Cabazitaxel
- +2 more
-
Alkmaar, Netherlands
- +18 more
Apr 14, 2022
Prostatic Tumors Trial in Worldwide (Radium-223 dichloride (Xofigo, BAY88-8223), Matching (normal saline), Abiraterone)
Active, not recruiting
- Prostatic Neoplasms
- Radium-223 dichloride (Xofigo, BAY88-8223)
- +3 more
-
Anchorage, Alaska
- +163 more
Jan 18, 2023
Prostate Gland Cancer, Which Spreads to Other Parts of Body, Who
Completed
- Metastatic Castration-resistant Prostate Cancer (mCRPC)
- Radium-223 (Xofigo, BAY88-8223)
- +2 more
-
Whippany, New JerseyUS Flatiron prostate cancer database
Dec 8, 2021
Metastatic Prostate Cancer Trial in Worldwide (Ipatasertib, Abiraterone, Placebo)
Active, not recruiting
- Metastatic Prostate Cancer
- Ipatasertib
- +3 more
-
Chandler, Arizona
- +183 more
Nov 24, 2022
Metastatic Castration-resistant Prostate Cancer Trial in Worldwide (Acapatamab, Enzalutamide, Abiraterone)
Active, not recruiting
- Metastatic Castration-resistant Prostate Cancer
- Acapatamab
- +3 more
-
Birmingham, Alabama
- +13 more
Jun 20, 2022
Castration-resistant Prostate Cancer, NSCLC, Colorectal Cancer Trial in Australia, United States (SM08502, Abiraterone,
Active, not recruiting
- Castration-resistant Prostate Cancer
- +2 more
- SM08502
- +5 more
-
Tucson, Arizona
- +19 more
Oct 18, 2022
Prostate Cancer Trial in Worldwide (AMG 509, Abiraterone, Enzalutamide)
Recruiting
- Prostate Cancer
- AMG 509
- +2 more
-
Duarte, California
- +18 more
Mar 17, 2022
Prostatic Tumors, Tumor Metastasis, Urogenital Tumors Trial in Worldwide (Abemaciclib, Abiraterone, Prednisone or Prednisolone)
Recruiting
- Prostatic Neoplasms
- +16 more
- Abemaciclib
- +3 more
-
Birmingham, Alabama
- +296 more
Jan 18, 2023
Prostate Cancer Trial in Honolulu (Denosumab, Enzalutamide, Abiraterone)
Terminated
- Prostate Cancer
- Denosumab
- +3 more
-
Honolulu, HawaiiUniversity of Hawaii Cancer Center
Nov 6, 2019
Prostate Cancer Trial in Worldwide (Enzalutamide, Abiraterone, Placebo for Enzalutamide)
Metastatic Castration-Resistant Prostate Cancer Trial in Worldwide ([Lu-177]-PNT2002, Abiraterone, Enzalutamide)
Recruiting
- Metastatic Castration-Resistant Prostate Cancer
- [Lu-177]-PNT2002
- +2 more
-
Tucson, Arizona
- +47 more
Jun 1, 2022
Prostatic Tumors Trial in Japan (Androgen-deprivation Therapy (ADT), Bicalutamide, Abiraterone)
Active, not recruiting
- Prostatic Neoplasms
- Androgen-deprivation Therapy (ADT)
- +6 more
-
Akita, Japan
- +76 more
Jan 19, 2023
Prostatic Tumors, Prostate Cancer, Tumor, Prostate Trial in Bethesda, Philadelphia (AMG 386, Abiraterone, Prednisone)
Completed
- Prostatic Neoplasms
- +3 more
- AMG 386
- +2 more
-
Bethesda, Maryland
- +1 more
Feb 11, 2019
Castration Levels of Testosterone, Metastatic Prostatic Adenocarcinoma, Stage IV Prostate Cancer AJCC v8 Trial in Mexico, United
Recruiting
- Castration Levels of Testosterone
- +4 more
- Abiraterone
- +14 more
-
Gilbert, Arizona
- +301 more
Nov 8, 2021
Metastatic Castration-Resistant Prostatic Cancer Trial in Australia, Canada (cabazitaxel, Abiraterone, Enzalutamide 160mg daily
Unknown status
- Metastatic Castration-Resistant Prostatic Cancer
- cabazitaxel
- +2 more
-
Box Hill, Victoria, Australia
- +14 more
Dec 4, 2017
Prostate Cancer Trial in New Brunswick (Abiraterone, ABT-263, Hydroxychloroquine)
Terminated
- Prostate Cancer
- Abiraterone
- +2 more
-
New Brunswick, New JerseyRutgers Cancer Institute of New Jersey
Mar 30, 2017
Urokinase Plasminogen Activator Receptor in Abiraterone Treated
Terminated
- Prostatic Neoplasms
- Abiraterone
- Prednisolone
-
Copenhagen, DenmarkUniversity Hospital of Copenhagen, Rigshospitalet
Nov 18, 2015